Literature DB >> 3871620

Coronary artery bypass grafting and hyperlipidaemia.

G Thompson, R Sapsford.   

Abstract

Mesh：

Year:  1985        PMID： 3871620      PMCID： PMC481748          DOI： 10.1136/hrt.53.3.237

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  29 in total

1.  Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia.

Authors:  R G Murray; A Tweddel; J L Third; I Hutton; W S Hillis; A R Lorimer; T D Lawrie
Journal:  Br Heart J       Date:  1975-12

2.  Clinical significance of the coronary arteriogram.

Authors:  D C Banks; E B Raftery; S Oram
Journal:  Br Heart J       Date:  1971-11

3.  Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique.

Authors:  R G Favaloro
Journal:  Ann Thorac Surg       Date:  1968-04       Impact factor: 4.330

4.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

Review 5.  Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.

Authors:  G Thompson
Journal:  Br Heart J       Date:  1984-06

6.  Long term follow-up after coronary artery bypass graft surgery. Progression and regression of disease in native coronary circulation and bypass grafts.

Authors:  R W Brower; K Laird-Meeter; P W Serruys; G T Meester; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-07

7.  Serum lipid levels in angiographically defined coronary artery disease.

Authors:  P F Cohn; S I Gabbay; W B Weglicki
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

8.  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Authors:  J F Brensike; R I Levy; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini; D J Moriarty
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

9.  Hypertriglyceridaemia and hypercoagulability.

Authors:  H C Simpson; J I Mann; T W Meade; R Chakrabarti; Y Stirling; L Woolf
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

10.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Authors:  N E Miller; F Hammett; S Saltissi; S Rao; H van Zeller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30
View more
  1 in total

Review 1.  Clinical consequences of hyperlipidaemia.

Authors:  G R Thompson
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.